Therapeutic Apheresis and Cell Collections

Cell Collections

Overview

Stem Cell Therapy

Cell and Gene Therapy

Granulocyte Collection

Protocols

Leveraging our 40 years of blood and cell processing expertise, Terumo Blood and Cell Technologies provides customized and comprehensive cell collection solutions to apheresis centers and cell manufacturers.

Whether you are trying to collect cells for autologous or allogeneic therapies using the Spectra Optia^® Apheresis System or improve the quality of the starting material using our data analytics services, we help you optimize your cell collections and perform safe, consistent procedures.

Stem Cell Therapy

Certain types of cancers and autoimmune diseases can be treated with the help of stem cell therapies,¹ which begin with collecting the optimal cells to support bone marrow recovery and blood cell production. Spectra Optia brings precision to your stem cell collections with multiple protocols and analytical tools to optimize them.

Instructional Video

Continuous Mononuclear Cell Collection (CMNC Procedure)

Giving you versatility and customization

Instructional Video

Mononuclear Collection
(MNC Procedure)

Reliability for your procedure performance

Cell and Gene Therapy

Every day, across the globe, demand is increasing for the manufacturing and commercialization of cell and gene therapies. This inspires new ideas for CAR T-cell therapies but also presents real challenges for cell manufacturers and collection sites to effectively scale. Leveraging our expertise and comprehensive data management solutions, we help our customers improve the quality of their starting material and get more insight into their cell collection process.

On-Demand Webinar

Challenges of Cell Collections for Cell Therapy Manufacturing: What Do We Want in the Bag?

Panel includes Krishnendu Roy, PhD; Sandeep Soni, MD; and Melinda Caltabano

2-Minute Video

5 Things Manufacturers Must Do to Scale Cell Collections

Featuring Matt Hemstreet, MBA

Granulocyte Collection

Granulocytes (PMNs) are collected from donors to help control infection after transplants, chemotherapy, and other life-saving treatments.² Spectra Optia continuously monitors and interprets the cell interface and adjusts collection accordingly to target just the desired cells. That, combined with unparalleled training and operator support, helps enable effective and efficient procedures.

Brochure

PMN Brochure

Giving you flexibility and optimization

Learn how in this brochure.

Download

Protocols

Because each patient’s needs are unique, we offer a variety of protocols to support apheresis and cell collections.

Learn More

Sources

Hawsawi YM, Al-Zahrani F, Mavromatis C, Baghdadi MA, Saggu S, Oyouni AAA. Technol Cancer Res Treat. 2018;17:1533033818806910.
National Institutes of Health Clinical Center. NIH Blood Bank: Granulocytes by apheresis. Updated 22 March 2022. Accessed 21 September 2022. https://clinicalcenter.nih.gov/blooddonor/donationtypes/granulocytes.html.

Let’s talk about your cell collection needs.

Fields marked * are required.

First Name:*

Last Name:*

Email:*

Country:*

Institution Type:*

Role:*

Company:*

Message:

Yes, I would like to receive future communications about Terumo Blood and Cell Technologies Cell Therapy Technologies.

I confirm that I have read and agree to the Terumo Blood and Cell Technologies Privacy Policy regarding the use of information.*

Submit

{{$index+1}}. {{s.label}}